Mechanism of Action
NK1 Receptor Preference
Physalaemin preferentially activates NK1 receptors (the substance P-preferring receptor), leading to Gq activation, PLC stimulation, and intracellular calcium mobilization. In the gastrointestinal tract, NK1 activation induces intestinal smooth muscle contraction and increases secretion. In the vasculature, it causes endothelium-dependent vasodilation.
Salivary and Exocrine Secretion
Like eledoisin and substance P, physalaemin is a potent stimulator of salivary gland secretion. It also stimulates pancreatic exocrine secretion through NK1 receptors on acinar cells. These secretagogue properties have been exploited in experimental models of exocrine gland function.
Research Summary
Tachykinin Receptor Pharmacology
PreclinicalPhysalaemin has been used as a reference agonist in comparative tachykinin receptor studies. Its potency profile across NK1, NK2, and NK3 receptors helped establish the selectivity requirements for each receptor subtype. Structure-activity relationship studies using physalaemin analogs identified the key C-terminal residues responsible for receptor recognition.
Antimicrobial Properties
PreclinicalLike many amphibian skin peptides, physalaemin displays secondary antimicrobial activity against bacteria and fungi at higher concentrations. This activity is related to its amphipathic helical character in membrane environments, separate from its receptor-mediated pharmacological actions.
Calculate your Physalaemin dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| NK receptor binding assays | 1-1000 nM | Single | Receptor binding / cell assay |
| Smooth muscle contraction | 10-100 nM | Single | Organ bath preparation |
Research use only. No therapeutic applications.
Interactions
Safety Profile
Physalaemin produces hypotension through vasodilation and may cause bronchoconstriction via airway smooth muscle NK1 activation. Not used therapeutically in humans. Used solely as a pharmacological research tool.
References
- [1]Anastasi A et al. (1964). Isolation and structure of physalaemin, the main active polypeptide of the skin of Physalaemus fuscumaculatus. Archives of Biochemistry and Biophysics, 108, 341-348.
- [2]Regoli D and Barabe J (1980). Pharmacology of bradykinin and related kinins. Pharmacological Reviews, 32(1), 1-46.